Maureen Rischmueller
Adelaide Medical School
Faculty of Health and Medical Sciences
Associate Professor Maureen Rischmueller is the Senior Consultant Rheumatologist, Rheumatology Department at The Queen Elizabeth Hospital, and Clinical Associate Professor, Discipline of Medicine, University of Adelaide.
Her main research interests are within the realm of inflammatory rheumatic diseases including Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, and vasculitis. Her translational research program investigates pathogenetic mechanisms, novel auto-antibodies, genetic risk factors, clinical manifestations, and new treatments for autoimmune rheumatic diseases.
-
Appointments
Date Position Institution name 2016 - ongoing Consultant Rheumatologist Royal Darwin Hospital, Darwin 2016 - ongoing Senior Consultant Rheumatologist The Queen Elizabeth Hospital 2015 - ongoing Staff Consultant Rheumatologist Queen Elizabeth Hospital, Adelaide 2014 - ongoing Associate Professor University of Adelaide, Adelaide 2004 - 2015 Director, Rheumatology Unit Queen Elizabeth Hospital, Adelaide -
Postgraduate Training
Date Title Institution Country 1993 Fellowship Royal Australasian College of Physicians, Sydney Australia 1985 MBBS University of Adelaide, Adelaide Australia -
Research Interests
-
Journals
Year Citation 2024 Lee, A. Y. S., Rischmueller, M., & Reed, J. H. (2024). Seronegative Sjögren Syndrome: A Forgotten Entity?. Journal of Rheumatology, 51(1), 7-9.
Scopus12024 Eades, L. E., Sines, J., Hoi, A. Y., Liddle, R., Kandane-Rathnayake, R., Morand, E. F., . . . Vincent, F. B. (2024). Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?. Seminars in Arthritis and Rheumatism, 65, 7 pages.
2024 Gordon, R. A., Nguyen, Y., Foulquier, N., Beydon, M., Gheita, T. A., Hajji, R., . . . Seror, R. (2024). The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation. Seminars in Arthritis and Rheumatism, 65, 6 pages.
2023 Flores-Chávez, A., Brito-Zerón, P., Ng, W. F., Szántó, A., Rasmussen, A., Priori, R., . . . Ramos-Casals, M. (2023). Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren’s syndrome. Clinical and Experimental Rheumatology, 41(12), 2437-2447.
2023 Brito-Zerón, P., Flores-Chávez, A., Ng, W. F., Horváth, I. F., Rasmussen, A., Priori, R., . . . Ramos-Casals, M. (2023). Exposure to air pollution as an environmental determinant of how Sjögren’s disease is expressed at diagnosis. Clinical and Experimental Rheumatology, 41(12), 2448-2457.
2023 Kivitz, A., Wells, A. F., Vargas, J. I., Baraf, H. S. B., Rischmueller, M., Klaff, J., . . . Durez, P. (2023). Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.. Rheumatol Ther, 10(4), 901-915.
2023 Fairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Australian Scleroderma Interest Group. (2023). Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.. Arthritis Research and Therapy, 25(1), 1-13.
Scopus4 WoS1 Europe PMC12023 Brito-Zerón, P., Flores-Chávez, A., Horváth, I. F., Rasmussen, A., Li, X., Olsson, P., . . . Sisó-Almirall, A. (2023). Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study. eClinicalMedicine, 61, 16 pages.
Scopus6 Europe PMC22023 Polmear, J., Hailes, L., Olshansky, M., Rischmueller, M., L'Estrange-Stranieri, E., Fletcher, A. L., . . . Good-Jacobson, K. L. (2023). Targeting BMI-1 to deplete antibody-secreting cells in autoimmunity. Clinical and Translational Immunology, 12(10), e1470-1-e1470-12.
2023 Hernández-Molina, G., Kostov, B., Brito-Zerón, P., Vissink, A., Mandl, T., Hinrichs, A. C., . . . De Miguel Campo, B. (2023). Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies. Rheumatology (United Kingdom), 62(1), 243-255.
Scopus16 WoS15 Europe PMC42023 Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2023). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). Nature Communications, 14(1), 598.
Scopus12022 Inanc, N., Kostov, B., Priori, R., Flores-Chavez, A., Carubbi, F., Szántó, A., . . . Brito-Zerón, P. (2022). Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome. Clinical and Experimental Rheumatology, 40(12), 2290-2297.
Scopus3 WoS2 Europe PMC32022 Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2022). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). Nature Communications, 13(1), 1 page.
Scopus22022 Scofield, R. H., Lewis, V. M., Cavitt, J., Kurien, B. T., Assassi, S., Martin, J., . . . Miller, F. W. (2022). 47XXY and 47XXX in Scleroderma and Myositis. ACR Open Rheumatology, 4(6), 528-533.
Scopus10 WoS7 Europe PMC62022 Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2022). Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.. Nature communications, 13(1), 17 pages.
Scopus28 WoS16 Europe PMC202022 Kerick, M., Acosta-Herrera, M., Simeón-Aznar, C. P., Callejas, J. L., Assassi, S., Carreira, P., . . . Ortega-Castro, R. (2022). Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine, 7(1), 12 pages.
Scopus3 WoS2 Europe PMC12021 Bossini-Castillo, L., Villanueva-Martin, G., Kerick, M., Acosta-Herrera, M., López-Isac, E., Simeón, C. P., . . . Martin, J. (2021). Genomic Risk Score impact on susceptibility to systemic sclerosis. Annals of the Rheumatic Diseases, 80(1), 118-127.
Scopus18 Europe PMC92021 Retamozo, S., Acar-Denizli, N., Horváth, I. F., Ng, W. F., Rasmussen, A., Dong, X., . . . Brito-Zerón, P. (2021). Influence of the age at diagnosis in the disease expression of primary Sjögren's syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. Clinical and Experimental Rheumatology, 39(6), S166-S174.
Scopus19 Europe PMC72021 Retamozo, S., Acar-Denizli, N., Horvath, I. F., Ng, W. -F., Rasmussen, A., Dong, X., . . . Brito-Zeron, P. (2021). Influence of the age at diagnosis in the disease expression of primary Sjogren's syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 39(6), S166-S174.
WoS62021 Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R. M., Ueki, Y., Atsumi, T., . . . van Vollenhoven, R. F. (2021). Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern Rheumatology, 31(3), 534-542.
Scopus4 WoS4 Europe PMC22021 Hoa, S., Bernatsky, S., Baron, M., Proudman, S., Stevens, W., Sahhar, J., . . . Nikpour, M. (2021). Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest, 160(6), 2158-2162.
Scopus5 WoS3 Europe PMC32021 Brito-Zerón, P., Melchor, S., Seror, R., Priori, R., Solans, R., Kostov, B., . . . Sánchez, I. (2021). SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients. Rheumatology (United Kingdom), 60(6), 2946-2957.
Scopus16 Europe PMC122021 Lyne, S. A., Downie-Doyle, S., Lester, S. E., Quinlivan, A., Toby Coates, P., Gordon, T. P., & Rischmueller, M. (2021). Primary Sjögren's syndrome in South Australia. Clinical and Experimental Rheumatology, 38(4), S57-S63.
Scopus3 Europe PMC22021 Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242.
Scopus1 WoS12021 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2021). Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care and Research, 73(5), 732-741.
Scopus13 WoS9 Europe PMC92020 Singh, M., Jackson, K. J. L., Wang, J. J., Schofield, P., Field, M. A., Koppstein, D., . . . Reed, J. H. (2020). Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell, 180(5), 878-894.
Scopus72 WoS63 Europe PMC462020 van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. -E. F., Chen, S., . . . Strand, V. (2020). Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Randomized, Double-blind, Active-comparator, Multi-center, Multi-country Trial.. Arthritis & rheumatology (Hoboken, N.J.), 72(10), 1607-1620.
Scopus118 WoS66 Europe PMC812020 Leonardo, N., Lester, S., Whittle, S., & Rischmueller, M. (2020). Review of gout clinic in a tertiary hospital setting.. Intern Med J, 50(1), 117-120.
Scopus5 WoS42020 Brito-Zerón, P., Acar-Denizli, N., Ng, W. -F., Horváth, I. F., Rasmussen, A., Seror, R., . . . Sjögren Big Data Consortium. (2020). Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.. Rheumatology (Oxford, England), 59(9), 2350-2359.
Scopus61 WoS52 Europe PMC312020 Patel, S., Morrisroe, K., Proudman, S., Hansen, D., Sahhar, J., Sim, M. R., . . . Australian Scleroderma Interest Group. (2020). Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology, 59(12), 3900-3905.
Scopus16 WoS11 Europe PMC42020 Reed, J. H., Verstappen, G. M., Rischmueller, M., & Bryant, V. L. (2020). When B cells break bad: development of pathogenic B cells in Sjögren's syndrome.. Clin Exp Rheumatol, 38(4), S271-S282.
Scopus13 Europe PMC62020 Ramezanpour, M., Hu, H., Lau, A., Liu, S., De Silva, A., Bolt, H., . . . Vreugde, S. (2020). Increased serum IgG4 associates with asthma and tissue eosinophilia in chronic rhinosinusitis patients. Pathogens, 9(10), 1-6.
Scopus2 WoS1 Europe PMC12020 Rubbert-Roth, A., Enejosa, J., Pangan, A. L., Haraoui, B., Rischmueller, M., Khan, N., . . . Xavier, R. M. (2020). Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.. The New England journal of medicine, 383(16), 1511-1521.
Scopus142 WoS135 Europe PMC882020 Lyne, S. A., Downie-Doyle, S., Lester, S. E., Quinlivan, A., Coates, P. T., Gordon, T. P., & Rischmueller, M. (2020). Primary Sjogren's syndrome in South Australia. Clinical and Experimental Rheumatology, 38(4), S57-S63. 2020 Acar-Denizli, N., Horváth, I. F., Mandl, T., Priori, R., Vissink, A., Hernandez-Molina, G., . . . Brito-Zerón, P. (2020). Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies. Clinical and Experimental Rheumatology, 38(4), S85-S94.
Scopus14 WoS12 Europe PMC42020 Reed, J. H., Verstappen, G. M., Rischmueller, M., & Bryant, V. L. (2020). When B cells break bad: development of pathogenic B cells in Sjogren's syndrome. Clinical and Experimental Rheumatology, 38(Suppl. 26), S-271-S-282.
WoS122019 Metwally, M., Thabet, K., Bayoumi, A., Nikpour, M., Stevens, W., Sahhar, J., . . . Eslam, M. (2019). IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Scientific Reports, 9(1), 14834.
Scopus18 WoS12 Europe PMC102019 López-Isac, E., Acosta-Herrera, M., Kerick, M., Assassi, S., Satpathy, A. T., Granja, J., . . . Chang, H. Y. (2019). GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nature Communications, 10(1), 14 pages.
Scopus85 WoS61 Europe PMC582019 Vincent, F. B., Lang, T., Kandane-Rathnayake, R., Downie-Doyle, S., Morand, E. F., & Rischmueller, M. (2019). Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome. Joint Bone Spine, 86(3), 393-395.
Scopus3 WoS4 Europe PMC12019 Retamozo, S., Acar-Denizli, N., Rasmussen, A., Horvath, I. F., Baldini, C., Priori, R., . . . Brito-Zeron, P. (2019). Systemic Manifestations of Primary Sjogren Syndrome out of the ESSDAI Classification: Prevalence and Clinical Relevance in a Large International, Multi-ethnic Cohort of Patients. ARTHRITIS & RHEUMATOLOGY, 71(3), 4 pages.
Europe PMC182019 Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F., & Rischmueller, M. (2019). Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome. Clinical and Experimental Rheumatology, 37(3), S254-S256.
Scopus4 WoS12019 Retamozo, S., Acar-Denizli, N., Rasmussen, A., Horváth, I. F., Baldini, C., Priori, R., . . . Brito-Zerón, P. (2019). Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clinical and experimental rheumatology, 37(3), S97-S106.
Scopus50 WoS282019 Acar-Denizli, N., Kostov, B., Ramos-Casals, M., Brito-Zerón, P., Morcillo, C., Brito-Zerón, P., . . . Perdriger, A. (2019). The Big Data Sjögren consortium: A project for a new data science era. Clinical and Experimental Rheumatology, 37(3), S19-S23.
Scopus18 Europe PMC52019 van der Heijde, D., Strand, V., Tanaka, Y., Keystone, E., Kremer, J., Zerbini, C. A. F., . . . Wagh, S. (2019). Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study. Arthritis and Rheumatology, 71(6), 878-891.
Scopus68 Europe PMC342019 Richard, N., Hudson, M., Wang, M., Gyger, G., Proudman, S., Stevens, W., . . . Baron, M. (2019). Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology, 58(4), 636-644.
Scopus32 WoS35 Europe PMC212019 Butler, E. A., Baron, M., Fogo, A. B., Frech, T., Ghossein, C., Hachulla, E., . . . Walker, U. A. (2019). Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis and Rheumatology, 71(6), 964-971.
Scopus32 WoS27 Europe PMC142019 Rischmueller, M., & Spurrier, A. (2019). Can Sjögren’s syndrome diagnosis and evaluation be stretched by elastography?. International Journal of Rheumatic Diseases, 22(2), 172-174.
Scopus1 WoS1 Europe PMC12019 Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F., & Rischmueller, M. (2019). Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome.. Clinical and experimental rheumatology, 37 Suppl 118(3), 254-256.
Europe PMC32019 Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., . . . Nikpour, M. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816.
Scopus32 WoS37 Europe PMC102018 Hsu, V., Denton, C., Domsic, R., Furst, D., Rischmueller, M., Stanislav, M., . . . Hough, D. (2018). Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: A phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Journal of Rheumatology, 45(3), 405-410.
Scopus31 WoS28 Europe PMC202018 Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Bird, P., Cook, N., . . . Thirunavukkarasu, K. (2018). Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.. Rheumatology and therapy, 5(2), 383-401.
Scopus11 WoS7 Europe PMC32018 Retamozo, S., Acar-Denizli, N., Ng, W. -F., Zeher, M., Rasmussen, A., Mandl, T., . . . Brito-Zeron, P. (2018). How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project). Clinical and Experimental Rheumatology, 36(Suppl 112), S102-S111.
Scopus132 Europe PMC532018 Vincent, F. B., Kandane-Rathnayake, R., Hoi, A. Y., Slavin, L., Godsell, J. D., Kitching, A. R., . . . Morand, E. F. (2018). Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. Lupus, 27(13), 2029-2040.
Scopus17 WoS12 Europe PMC112018 Harris, V., Sharma, R., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2018). Corrigendum to “Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome” [Clin. Immunol. 168 (2016) 25–29](S1521661616300614)(10.1016/j.clim.2016.04.002). Clinical Immunology, 187, 137-138.
Scopus1 WoS1 Europe PMC12017 Lau, A., Lester, S., Moraitis, S., Ou, J., Psaltis, A., McColl, S., . . . Vreugde, S. (2017). Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis. Journal of Allergy and Clinical Immunology, 139(4), 1371-1373.
Scopus20 WoS18 Europe PMC82017 Brito-Zerón, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Seror, R., Theander, E., . . . Ramos-Casals, M. (2017). Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Annals of the Rheumatic Diseases, 76(6), 1042-1050.
Scopus134 WoS114 Europe PMC682017 Nossent, J., Lester, S., Rischmueller, M., & Zalewski, P. (2017). No zinc deficiency but a putative immunosuppressive role for labile Zn in patients with systemic autoimmune disease. Current Rheumatology Reviews, 13(1), 59-64.
Scopus4 WoS4 Europe PMC22017 Morrisroe, K., Stevens, W., Sahhar, J., Rabusa, C., Nikpour, M., Proudman, S., . . . Zochling, J. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research and Therapy, 19(1), 42-1-42-10.
Scopus67 WoS64 Europe PMC312017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G., Zochling, J., . . . ustralian Scleroderma Interest Group (ASIG). (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 35(4 Suppl. 106), S130-S137.
Scopus10 WoS4 Europe PMC52017 Maundrell, A., Lester, S., Rischmueller, M., Hill, C., Cleland, L. G., Blumbergs, P., . . . Limaye, V. (2017). The PTPN22 gene is associated with idiopathic inflammatory myopathy. Muscle and Nerve, 55(2), 270-273.
Scopus3 WoS4 Europe PMC22017 Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., . . . Walker, J. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 122.
Scopus48 WoS51 Europe PMC302017 Li, H., Reksten, T. R., Ice, J. A., Kelly, J. A., Adrianto, I., Rasmussen, A., . . . Sivils, K. L. (2017). Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics, 13(6), 29 pages.
Scopus51 WoS45 Europe PMC412017 Sharma, R., Harris, V., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2017). Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis and Rheumatology, 69(11), 2187-2192.
Scopus38 WoS30 Europe PMC212017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G. S., Zochling, J., . . . Walker, J. (2017). Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 2(3), 188-195.
Scopus7 WoS82017 Proudman, S. M., Huq, M., Stevens, W., Wilson, M. E., Sahhar, J., Baron, M., . . . Hij, A. (2017). What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders, 2(3), 169-182.
Scopus20 WoS202017 Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., . . . Walczak, A. (2017). Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. The Lancet, 390(10093), 457-468.
Scopus339 Europe PMC2022016 Rischmueller, M., Tieu, J., & Lester, S. (2016). Primary Sjögren's syndrome. Best Practice and Research: Clinical Rheumatology, 30(1), 189-220.
Scopus83 WoS75 Europe PMC412016 Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., G Walker, J., . . . Nikpour, M. (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 129-136.
Scopus16 WoS10 Europe PMC82016 Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Merriman, T. R. (2016). Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology, 55(8), 1421-1430.
Scopus15 WoS10 Europe PMC102016 Wechalekar, M., Lester, S., Hill, C., Lee, A., Rischmueller, M., Smith, M., . . . Proudman, S. (2016). Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remission. Arthritis Care and Research, 68(11), 1616-1623.
Scopus33 WoS32 Europe PMC202016 Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3.
Scopus8 WoS10 Europe PMC42016 Harris, V., Sharma, R., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2016). Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical Immunology, 168, 25-29.
Scopus66 WoS47 Europe PMC462016 Liu, K., Kurien, B., Zimmerman, S., Kaufman, K., Taft, D., Kottyan, L., . . . Hal Scofield, R. (2016). X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjögren's syndrome. Arthritis and Rheumatology, 68(5), 1290-1300.
Scopus108 WoS93 Europe PMC692015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-551.
Scopus28 WoS26 Europe PMC142015 Wechalekar, M. D., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. 2015 Patterson, K., Roberts-Thomson, P., Lester, S., Tan, J., Hakendorf, P., Rischmueller, M., . . . Walker, J. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis and Rheumatology, 67(12), 3234-3244.
Scopus89 WoS81 Europe PMC482015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Salazar, G. (2015). Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clinical and Experimental Rheumatology, 33(4 (suppl.91)), 131-135.
Scopus51 WoS44 Europe PMC282015 Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140.
Scopus20 WoS20 Europe PMC132015 Merriman, T. R., Phipps-Green, A., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Rasheed, H. (2015). Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. 2015 Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(1), 23.
Scopus89 WoS87 Europe PMC602015 Kottyan, L., Zoller, E., Bene, J., Lu, X., Kelly, J., Rupert, A., . . . Kaufman, K. (2015). The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics, 24(2), 582-596.
Scopus62 WoS55 Europe PMC422015 Proudman, S., James, M., Spargo, L., Metcalf, R., Sullivan, T., Rischmueller, M., . . . Cleland, L. (2015). Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases, 74(1), 89-95.
Scopus121 WoS104 Europe PMC732014 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39.
Scopus53 WoS46 Europe PMC282014 Dunstan, E., Lester, S., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2014). TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clinical and Experimental Rheumatology, 32(SUPPL.82), S26-S29.
Scopus4 WoS4 Europe PMC42014 Zochling, J., Newell, F., Charlesworth, J., Leo, P., Stankovich, J., Cortes, A., . . . Brown, M. (2014). An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Research & Therapy, 16(5), 438-1-438-7.
Scopus51 WoS47 Europe PMC362014 Lester, S., Hewitt, A., Bradbury, L., De Smit, E., Harrison, A., Jones, G., . . . Hill, C. L. (2014). PTPN22 rs2476601 and Susceptibility to Biopsy Proven Giant Cell Arteritis (GCA) in an Australian Sample.. ARTHRITIS & RHEUMATOLOGY, 66, S341. 2013 Lester, S., Nossent, J., & Rischmueller, M. (2013). Comment on 'No association of primary Sjögren's syndrome with Fcγ receptor gene variants'. Genes and Immunity, 14(8), 530-531.
Scopus1 WoS12013 Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4.
WoS1 Europe PMC12013 Jardeleza, C., Miljkovic, D., Baker, L., Boase, S., Tan, N., Koblar, S., . . . Vreugde, S. (2013). Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Rhinology, 51(4), 315-322.
Scopus11 WoS11 Europe PMC92013 Lessard, C., & Rischmueller, M. (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nature Genetics, 45(11), 1284-1294.
Scopus393 WoS343 Europe PMC2712013 Lester, S., Stokes, L., Skarratt, K., Gu, B., Sivils, K., Lessard, C., . . . Rischmueller, M. (2013). Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome. Arthritis Research & Therapy, 15(4), 1-10.
Scopus21 WoS20 Europe PMC122013 Tan, J., & Rischmueller, M. (2013). Sjogren's syndrome in 2013. Medicine Today, 14(6), 26-35.
Scopus12013 Nossent, J., Becker-Merok, A., Rischmueller, M., & Lester, S. (2013). Susceptibility for lupus nephritis by low copy number of the FCGR3B gene is linked to increased levels of pathogenic autoantibodies. Autoimmune Diseases, 2013, 1-7.
Scopus8 WoS6 Europe PMC52013 Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357.
Scopus17 WoS14 Europe PMC112013 Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., . . . Nikpour, M. (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 15(6), R193-1-R193-11.
Scopus51 WoS49 Europe PMC332013 Usmani, Z., Hlavac, M., Rischmueller, M., Heraganahally, S., Hilditch, C., Lester, S., . . . McEvoy, R. (2013). Response to: The interaction of Sjogren's syndrome, gastroesophageal reflux and sleep by Tufik et al.. Sleep Medicine, 14(2), 222-223.
2013 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Ahern, M., Cleland, L., . . . Hill, C. (2013). EPIDEMIOLOGY OF BIOPSY-PROVEN GIANT CELL ARTERITIS (GCA) IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 43, 21. 2013 McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., . . . Sterry, W. (2013). Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. The Lancet, 382(9894), 780-789.
Scopus662 Europe PMC4082012 Black, R., Roach, D., Lester, S., Rischmueller, M., & Hill, C. (2012). THE USE OF TEMPORAL ARTERY ULTRASOUND IN THE DIAGNOSIS OF GIANT CELL ARTERITIS AT THE QUEEN ELIZABETH HOSPITAL. INTERNAL MEDICINE JOURNAL, 42, 24. 2012 Nossent, J., Rischmueller, M., & Lester, S. (2012). Low copy number of the Fc-γ receptor ₃B gene FCGR₃B is a risk factor for primary Sjögren's syndrome. Journal of Rheumatology, 39(11), 2142-2147.
Scopus31 WoS29 Europe PMC262012 Usmani, Z., Hlavac, M., Rischmueller, M., Heraganahally, S., Hilditch, C., Lester, S., . . . McEvoy, R. (2012). Sleep disordered breathing in patients with primary Sjögren's syndrome: A group controlled study. Sleep Medicine, 13(8), 1066-1070.
Scopus42 WoS35 Europe PMC222012 Lester, S., Rischmueller, M., Tan, L., Wormald, P., Zalewski, P., Hamilton-Bruce, M., . . . Hill, C. (2012). Sicca symptoms and their association with chronic rhinosinusitis in a community sample. The Open Rheumatology Journal, 6(1), 170-174.
Scopus8 Europe PMC52012 Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4.
Scopus5 WoS7 Europe PMC52012 Graf, S., Lester, S., Nossent, J., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy, 14(1), 1-7.
Scopus33 WoS33 Europe PMC242012 Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322.
Scopus47 WoS43 Europe PMC312012 Tran, H., Lewis, M., Tan, L. W., Lester, S., Baker, L., Ng, J., . . . Lang, C. (2012). Immunolocalization of NLRP3 inflammasome in normal murine airway epithelium and changes following induction of ovalbumin-induced airway inflammation. Journal of Allergy, Online(819176), 1-13.
Europe PMC352011 Ninan, J., Nguyen, A., Cole, A., Rischmueller, M., Dodd, T., Roberts-Thomson, P., & Hill, C. (2011). Mortality in patients with biopsy-proven giant cell arteritis: A South Australian population-based study. Journal of Rheumatology, 38(10), 2215-2217.
Scopus47 WoS46 Europe PMC292011 Tran, H., Rischmueller, M., Lester, S., Tan, L., Lewis, M., Koblar, S., . . . Zalewski, P. (2011). INFLAMMASOME ACTIVATION IS IMPLICATED IN DISEASE PATHOGENESIS IN ASTHMA AND PRIMARY SJOGREN'S SYNDROME. INTERNAL MEDICINE JOURNAL, 41, 9. 2011 Gilboa-Geffen, A., Wolf, Y., Hanin, G., Melamed-Book, N., Pick, M., Bennett, E. R., . . . Soreq, H. (2011). Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. PLoS ONE, 6(12), e28727.
Scopus27 Europe PMC202010 Cobb, B. L., Fei, Y., Jonsson, R., Bolstad, A. I., Brun, J. G., Rischmueller, M., . . . Sawalha, A. H. (2010). Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome. Annals of the Rheumatic Diseases, 69(9), 1731-1732.
Scopus30 WoS27 Europe PMC212010 Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80.
Scopus18 WoS14 Europe PMC102010 Hill, C., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology, 49(4), 756-759.
Scopus20 WoS20 Europe PMC142010 Hill, C. L., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis (vol 49, pg 756, 2010). RHEUMATOLOGY, 49(11), 2230.
2008 Tak, P., Thurlings, R., Rossier, C., Nestorov, I., Dimic, A., Mircetic, V., . . . Munafo, A. (2008). Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis and Rheumatism, 58(1), 67-72.
Scopus186 Europe PMC1392008 Nossent, J., Lester, S., Zahra, D., Mackay, C., & Rischmueller, M. (2008). Polymorphism in the 5 ' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome. Rheumatology, 47(9), 1311-1316.
Scopus60 WoS52 Europe PMC362008 Cai, F., Lester, S., Lu, T., Keen, H., Boundy, K., Proudman, S., . . . Rischmueller, M. (2008). Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Research & Therapy, 10(2), R31-1-R31-10.
Scopus37 WoS32 Europe PMC212008 Lester, S., McLure, C., Williamson, J., Bardy, P., Rischmueller, M., & Dawkins, R. (2008). Epistasis between the MHC and the RCAα block in primary Sjögren syndrome. Annals of the Rheumatic Diseases, 67(6), 849-854.
Scopus15 WoS14 Europe PMC92008 Cobb, B., Kaufman, K., Wang, Y., Kelly, J., Jonsson, R., Bolstad, A., . . . Harley, J. (2008). Association of Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with BLK. Clinical Immunology, 127 Suppl, S41.
2008 Hilditch, C., McEvoy, R., George, K., Thompson, C., Ryan, M., Rischmueller, M., & Catcheside, P. (2008). Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjogren's syndrome. Sleep, 31(3), 367-374.
Scopus24 WoS23 Europe PMC192007 Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111.
Scopus62 WoS62 Europe PMC442007 Lester, S., Downie-Doyle, S., & Rischmueller, M. (2007). CTLA4 polymorphism and primary Sjögren's syndrome. Arthritis Research and Therapy, 9(3), 1 page.
Scopus3 WoS3 Europe PMC22006 Tsopelas, C., Penglis, P., Miller, D., Rischmueller, M., & Bartholomeusz, F. (2006). Evaluation of Tc-99m-immunoglobulins for imaging infection in the rat. Journal of Labelled Compounds & Radiopharmaceuticals, 49(10), 915-928.
Scopus2 WoS12006 Downie-Doyle, S., Bayat, N., Rischmueller, M., & Lester, S. (2006). Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis and Rheumatism, 54(8), 2434-2440.
Scopus55 WoS52 Europe PMC392005 Smith, A., Jackson, M., Wang, F., Cavill, D., Rischmueller, M., & Gordon, T. (2005). Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. Human Immunology, 66(4), 411-416.
Scopus32 Europe PMC192005 Cox, S., Walker, J., Coleman, M., Rischmueller, M., Proudman, S., Smith, M., . . . Roberts-Thomson, P. (2005). Isolated pulmonary hypertension in scleroderma. Internal Medicine Journal, 35(1), 28-33.
Scopus61 WoS58 Europe PMC422004 Mullighan, C., Heatley, S., Lester, S., Rischmueller, M., Gordon, T., & Bardy, P. (2004). Fas gene promoter polymorphisms in primary Sjogren's syndrome. Annals of the Rheumatic Diseases, 63(1), 98-101.
Scopus22 WoS22 Europe PMC282003 Cai, F., Rischmueller, M., Pile, K., & Brady, S. (2003). Dysphagia associated with lower thoracic spondylosis. Rheumatology, 42(12), 1575-1576.
Scopus8 WoS7 Europe PMC42003 Walker, J., Gordon, T., Lester, S., Downie-Doyle, S., McEvoy, R., Pile, K., . . . Rischmueller, M. (2003). Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. Journal of Rheumatology, 30(11), 2406-2412.
Scopus54 WoS52 Europe PMC292003 Walker, J., Ahern, M., Smith, M., Coleman, M., Pile, K., Rischmueller, M., . . . Roberts-Thomson, P. (2003). Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Internal Medicine Journal, 33(5-6), 216-220.
Scopus62 WoS54 Europe PMC362003 Lester, S., Danda, D., Cavill, D., Pile, K., Downie-Doyle, S., & Rischmueller, M. (2003). Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis and Rheumatism, 48(11), 3293-3294.
Scopus2 WoS22003 Iyngkaran, P., Limaye, V., Hill, C., Henderson, D., Pile, K. D., & Rischmueller, M. (2003). Rheumatoid vasculitis following influenza vaccination [7]. Rheumatology, 42(7), 907-909.
Scopus29 WoS27 Europe PMC192002 Lester, S., Limaye, V., Downie-Doyle, S., Pile, K. D., Bardy, P., Gordon, T. P., . . . Hurme, M. (2002). No evidence of an association between the interleukin-10 promoter GCC allele and primary Sjögren's syndrome: Comment on the article by Hulkkonen et al (multiple letters) [3]. Arthritis and Rheumatism, 46(6), 1694-1696.
Scopus3 WoS3 Europe PMC32002 Downie-Doyle, S., Lester, S., Bardy, P., Gordon, T., Rischmueller, M., & Pile, K. (2002). Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's Syndrome. Genes and Immunity, 3(Suppl 1), S63-S65.
Scopus5 WoS5 Europe PMC32001 Burnet, S., Mahadevan, G., Lee, A., & Rischmueller, M. (2001). Sacral insufficiency fracture - A case of post-coital back pain [2]. Rheumatology, 40(9), 1065-1066.
Scopus5 Europe PMC32001 Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Bardy, P., Gordon, T. P., & Rischmueller, M. (2001). Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome (vol 27, pg 2945, 2000). JOURNAL OF RHEUMATOLOGY, 28(3), 684.
WoS22001 Gordon, T. P., Bolstad, A. I., Rischmueller, M., Jonsson, R., & Waterman, S. A. (2001). Autoantibodies in primary Sjögren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity, 34(2), 123-132.
Scopus82 Europe PMC522001 Rischmueller, M., Limaye, V., & Lester, S. (2001). Erratum: Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome (Journal of Rheumatology (2000) 27 (2945-2949)). Journal of Rheumatology, 28(3), 684. 2000 Goldblatt, F., Beroukas, D., Gillis, D., Cavill, D., Bradwell, A., Rischmueller, M., & Gordon, T. P. (2000). Antibodies to ab blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms. Journal of Rheumatology, 27(10), 2382-2388.
Scopus9 WoS6 Europe PMC52000 Mullighan, C. G., Heatley Sue, B., Bardy, P. G., Lester, S., Rischmueller, M., & Gordon, T. P. (2000). Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis and Rheumatism, 43(12), 2851-2852.
Scopus14 WoS15 Europe PMC82000 Couper, J., Kallincos, N., Pollard, A., Honeyman, M., Prager, P., Harrison, L., & Rischmueller, M. (2000). Toxic shock syndrome associated with newly diagnosed type 1 diabetes. Journal of Paediatrics and Child Health, 36(3), 279-282.
Scopus7 WoS6 Europe PMC32000 Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Rischmueller, M., Bardy, P., & Gordon, T. (2000). Polymorphisms of the Interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjgren's Syndrome. Journal of Rheumatology, 27(12), 2945-2946.
Scopus18 WoS19 Europe PMC132000 Waterman, S. A., Gordon, T. P., & Rischmueller, M. (2000). Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis and Rheumatism, 43(7), 1647-1654.
Scopus222 WoS197 Europe PMC1311999 Coates, T., Slavotinek, J., Rischmueller, M., Schultz, D., Anderson, C., Dellamelva, M., . . . Gordon, T. (1999). Cerebral white matter lesions in primary sjogren's syndrome: a controlled study. Journal of Rheumatology, 26(6), 1301-1305.
Scopus66 Europe PMC331998 McCluskey, J., Farris, A. D., Keech, C. L., Purcell, A. W., Rischmueller, M., Kinoshita, G., . . . Gordon, T. P. (1998). Determinant spreading: Lessons from animal models and human disease. Immunological Reviews, 164(1), 209-229.
Scopus123 Europe PMC801998 Rischmueller, M., Lester, S., Chen, Z., Champion, G., Van Den Berg, R., Beer, R., . . . Gordon, T. (1998). HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clinical and Experimental Immunology, 111(2), 365-371.
Scopus90 Europe PMC551997 Burrows, S. R., Silins, S. L., Cross, S. M., Peh, C. A., Rischmueller, M., Burrows, J. M., . . . McCluskey, J. (1997). Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. European Journal of Immunology, 27(1), 178-182.
Scopus35 WoS33 Europe PMC311997 Burrows, S. R., Silins, S. L., Khanna, R., Burrows, J. M., Rischmueller, M., McCluskey, J., & Moss, D. J. (1997). Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. European Journal of Immunology, 27(7), 1726-1736.
Scopus155 Europe PMC1131996 Rischmueller, M., Davies, R. P., & Smith, M. D. (1996). Three year follow-up of a case of giant cell arteritis presenting with a chronic couch and upper limb ischaemic symptoms. British Journal of Rheumatology, 35(8), 800-802.
Scopus17 Europe PMC81996 Rischmueller, M., Lester, S., McCluskey, J., Beer, R., Coates, T., & Gordon, T. P. (1996). Non-precipitating and precipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome are associated with distinct MHC phenotypes.. ARTHRITIS AND RHEUMATISM, 39(9), 1558. 1996 Rischmueller, M., Burrows, S., Moss, D., Gordon, T., Coates, T., & McCluskey, J. (1996). Evidence for normal T cell tolerance in primary Sjogren's syndrome. ARTHRITIS AND RHEUMATISM, 39(9), 1559. 1996 Beer, R., Rischmueller, M., Coates, T., Purcell, A., Keech, C., McCluskey, J., & Gordon, T. (1996). Nonprecipitating anti-La (SS-B) autoantibodies in primary Sjögren's syndrome. Clinical Immunology and Immunopathology, 79(3), 314-318.
Scopus34 Europe PMC201996 Keech, C., Howarth, S., Coates, T., Rischmueller, M., McCluskey, J., & Gordon, T. (1996). Rapid and sensitive detection of anti-Ro (SS-A) antibodies by indirect immunofluorescence of 60kDa Ro Hep-2 transfectants. Pathology, 28(1), 54-57.
Scopus28 Europe PMC121995 Rischmueller, M., McNeilage, L. J., McCluskey, J., & Gordon, T. (1995). Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle. Clinical and Experimental Immunology, 101(1), 39-44.
Scopus15 Europe PMC101994 Gordon, T., Topfer, F., Keech, C., Reynolds, P., Chen, W., Rischmueller, M., & Mccluskey, J. (1994). How does autoimmunity to la and ro initiate and spread?. Autoimmunity, 18(2), 87-92.
Scopus18 Europe PMC111992 Roberts-Thomson, P. J., Rischmueller, M., Kwiatek, R. A., Soden, M., Ahern, M. J., Hill, W. R., & Geddes, R. A. (1992). Rheumatic manifestations of infective endocarditis. Rheumatology International, 12(2), 61-63.
Scopus29 Europe PMC15 -
Conference Papers
Year Citation 2022 Nagel, A., Khatri, B., Radziszewski, M., Wiley, M., Stolarczyk, A., Joachims, M., . . . Lessard, C. (2022). Autophagy-related Risk Loci in Systemic Lupus Erythematous and Sjogren's Disease. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3982-3983). PA, Philadelphia: WILEY. 2022 Wiley, M., Khatri, B., Tessneer, K., Joachims, M., Stolarczyk, A., Nagel, A., . . . Lessard, C. (2022). Fine Mapping of the Sjogren's Disease and Systemic Lupus Erythematosus <i>DDX6</i>-<i>CXCR5</i> Risk Interval Reveals Common SNPs with Functional Significance in Immune and Salivary Gland Cells. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3981-3982). PA, Philadelphia: WILEY. 2022 Merriman, T., Matsuo, H., Takei, R., Leask, M., Topless, R., Shirai, Y., . . . Major, T. (2022). A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3338-3341). PA, Philadelphia: WILEY. 2022 Radziszewski, M., Wiley, M., Khatri, B., Tessneer, K., Rasmussen, A., Bowman, S., . . . Lessard, C. (2022). Transcriptome-Wide Association Study of Sjogren's Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 2223-2225). PA, Philadelphia: WILEY. 2022 Wiley, M. M., Khatri, B., Tessneer, K. L., Joachims, M. L., Stolarczyk, A. M., Nagel, A., . . . Lessard, C. (2022). SJOGREN'S DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVALS REVEAL COMMON SNPS WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE AND SALIVARY GLAND CELLS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 269-270). Copenhagen, DENMARK: BMJ PUBLISHING GROUP.
WoS12022 Aghakhanian, F., Wiley, M. M., Khatri, B., Tessneer, K. L., Rasmussen, A., Bowman, S. J., . . . Lessard, C. (2022). INTEGRATION OF GWAS AND EPIGENETIC STUDIES IDENTIFIES NOVEL GENES THAT ALTER EXPRESSION IN THE MINOR SALIVARY GLAND IN SJOGREN'S DISEASE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 72-73). Copenhagen, DENMARK: BMJ PUBLISHING GROUP.
2022 Kivitz, A., Wells, A. F., Vargas, J. I., Baraf, H. S. B., Rischmueller, M., Klaff, J., . . . Durez, P. (2022). LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 620-621). Copenhagen, DENMARK: BMJ PUBLISHING GROUP.
2022 Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Chin, A., Lester, S., Khoo, T., Burnet, S., Tieu, J., Rischmueller, M., . . . Hill, C. (2022). LYMPHOPAENIA IN RHEUMATOID ARTHRITIS (RA): A SINGLE CENTRE AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 29). WILEY. 2022 Hutton, I., Rischmueller, M., Bird, P., Latymer, M., Gruben, D., & Thorat, A. (2022). USABILITY AND ACCEPTABILITY OF A NEW AUTOINJECTOR DEVICE AND ITS ASSOCIATED APP IN AUSTRALIAN RHEUMATOLOGY PATIENTS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 24-25). WILEY. 2022 Radziszewski, M., Wiley, M., Khatri, B., Tessneer, K., Rasmussen, A., Bowman, S. J., . . . Lessard, C. J. (2022). TRANSCRIPTOME-WIDE ASSOCIATION STUDY OF SJOGREN'S DISEASE RISK ALLELES IDENTIFIES NOVEL GENES WITH ALTERED EXPRESSION IN MINOR SALIVARY GLAND AND OTHER TISSUES. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 17). CLINICAL & EXPER RHEUMATOLOGY. 2022 Wiley, M., Khatri, B., Tessneer, K., Joachims, M., Stolarczyk, A., Nagel, A., . . . Lessard, C. J. (2022). FINE MAPPING OF THE DDX6-CXCR5 RISK INTERVAL REVEALS SNPS IN SJOGREN'S DISEASE WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE CELLS AND SALIVARY GLAND. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 14). CLINICAL & EXPER RHEUMATOLOGY. 2022 Nagel, A., Khatri, B., Radziszewski, M., Wiley, M., Stolarczyk, A., Joachims, M., . . . Lessard, C. J. (2022). AUTOPHAGY-RELATED PRDM1-ATG5 RISK LOCUS IN SJOGREN'S DISEASE. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 26). CLINICAL & EXPER RHEUMATOLOGY. 2022 Retamozo, S., Szanto, A., Li, X., Rasmussen, A., Ng, F., Dong, X., . . . Ramos-Casals, M. (2022). INFLUENCE OF EPIDEMIOLOGY AND ETHNICITY ON SYSTEMIC EXPRESSION OF PRIMARY SJOGREN SYNDROME AT DIAGNOSIS: WORLDWIDE PATTERNS IN 14,836 PATIENTS (2022 SJOGREN BIG DATA PROJECT). In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 57). CLINICAL & EXPER RHEUMATOLOGY. 2022 Flores-Chavez, A., Horvath, F. I., Li, X., Rasmussen, A., Ng, F., Dong, X., . . . Akasbi, M. (2022). KEY FEATURES AT DIAGNOSIS OF PRIMARY SJOGREN SYNDROME IN 15,652 PATIENTS: 2022 SJOGREN BIG DATA PROJECT. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 93). CLINICAL & EXPER RHEUMATOLOGY. 2021 Rubbert-Roth, A., Xavier, R., Haraoui, B., Baraf, H. S. B., Rischmueller, M., Martin, N., . . . Cush, J. (2021). CLINICAL RESPONSES TO UPADACITINIB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS BY TYPE OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG: DATA FROM THE PHASE 3 SELECT-CHOICE STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 580). BMJ PUBLISHING GROUP.
WoS22020 Quinlivan, A., Downie-Doyle, S., Lester, S., Gordon, T., & Rischmueller, M. (2020). OBSERVATIONS FROM AN AUSTRALIAN SJOGREN'S COHORT. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 28). WILEY. 2019 van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. F., Chen, S., . . . Strand, V. (2019). A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. In JCR-JOURNAL OF CLINICAL RHEUMATOLOGY Vol. 25 (pp. S4). LIPPINCOTT WILLIAMS & WILKINS. 2019 van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, F., Chen, S., . . . Strand, V. (2019). A PHASE 3, RANDOMISED CONTROLLED TRIAL COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 58 (pp. 64). Birmingham, ENGLAND: OXFORD UNIV PRESS.
WoS12018 Khanam, S., Joachims, M. L., Means, N., Adrianto, I., Rasmussen, A., Bowman, S. J., . . . Lessard, C. J. (2018). Functional characterization of the Sjogren's syndrome-associated locus <i>DDX6</i>-<i>CXCR5</i>. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 36 (pp. S286-S287). CLINICAL & EXPER RHEUMATOLOGY. 2018 Khanam, S., Joachims, M. L., Means, N., Omdal, R., Wahren-Herlenius, M., Alevizos, I., . . . Lessard, C. (2018). FUNCTIONAL CHARACTERIZATION OF THE SJOGREN'S SYNDROME-ASSOCIATED LOCUS DDX6-CXCR5. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 1267). Amsterdam, NETHERLANDS: BMJ PUBLISHING GROUP.
2018 van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. -E., Chen, S., . . . Strand, V. (2018). A Phase 3, Randomized, Controlled Trial Comparing Upadacitinib Monotherapy to MTX Monotherapy in MTX-Naive Patients with Active Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 3 pages). IL, Chicago: WILEY.
WoS42018 Tesser, J., St John, G., Kimura, T., Fiore, S., Rischmueller, M., Maldonado-Cocco, J. A., . . . Kaine, J. (2018). Liver Function Test Levels with Sarilumab Treatment in Phase 3 Trials: Analysis By Baseline Liver Function Test (LFT) Level. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 3 pages). IL, Chicago: WILEY. 2018 Retamozo, S., Acar-Denizli, N., Ng, W. -F., Zeher, M., Rasmussen, A., Mandl, T., . . . Brito-Zeron, P. (2018). How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project). In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. 2016 Bird, P., Rischmueller, M., Feletar, M., Grant, G., Staples, M. P., & Hall, S. (2016). Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. 2016 Hall, S., Nash, P., Rischmueller, M., Wiid, Z., Witcombe, D., Gruben, D., . . . Lukic, T. (2016). Efficacy of Tofacitinib in Patients Who Are Inadequate Responders to Disease-Modifying Antirheumatic Drugs According to Early Versus Late Duration of Rheumatoid Arthritis: Post-Hoc Analysis of Data from Phase 3 Trials. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY.
WoS22014 Merriman, T., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Rasheed, H. (2014). ASSOCIATION OF THE TOLL-LIKE RECEPTOR 4 (TLR4) GENE WITH GOUT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 73 (pp. 354). Paris, FRANCE: BMJ PUBLISHING GROUP.
WoS22013 Liu, K., Kaufman, K. M., James, J. A., Jonsson, R., Kurien, B. T., Mariette, X., . . . Scofield, R. H. (2013). Sex Bias In Autoimmune Diseases: Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjogren's Syndrome (SS) Supports The Gene Dose Hypothesis. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S379). San Diego, CA: WILEY-BLACKWELL.
WoS22012 Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Jonsson, R., Illei, G. G., . . . Sivils, K. M. (2012). A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S1133). Washington, DC: WILEY-BLACKWELL.
WoS22011 Nossent, J. C., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). Interferon-Alpha Activation in Relation to Pro-Inflammatory Cytokines and Anti-Ro/La Response in Primary Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S186). Chicago, IL: WILEY. 2011 Nossent, J. C., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). Low Copy Number of Fcgamma Receptor 3B Gene Is a Disease Susceptibility and Severity Factor in Primary Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S389). Chicago, IL: WILEY.
WoS22011 Lessard, C. J., Ice, J. A., Adrianto, I., Kelly, J. A., Jonsson, R., Illei, G. G., . . . Moser, K. L. (2011). A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with <i>MHC</i>, <i>IRF5</i>, and <i>BLK</i>. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S184). Chicago, IL: WILEY.
WoS22011 Lessard, C. J., Adrianto, I., Ice, J. A., Kelly, J. A., Jonsson, R., Illei, G. G., . . . Moser, K. L. (2011). Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies <i>PRKRA</i> as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S303-S304). Chicago, IL: WILEY. 2011 Usmani, Z. A., Catcheside, P., Antic, N., Rischmueller, M., Smith, M., Gordon, T., & Mcevoy, R. D. (2011). Surfactant for OSA in patients with primary Sjogren's syndrome-a randomised, placebo controlled, cross over study. In JOURNAL OF SLEEP RESEARCH Vol. 20 (pp. 43). Sydney, AUSTRALIA: WILEY-BLACKWELL. 2011 Dillon, S. P., Kao, L., Kaufman, K. M., Ice, J. A., Omdal, R., Mariette, X., . . . Scofield, R. H. (2011). Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S251). Chicago, IL: WILEY.
WoS22008 Cobb, B. L., Wang, Y., Kaufman, K. M., Guthridge, J., Jonsson, R., Bolstad, A. I., . . . Harley, J. B. (2008). Association of BLK with Sjogren's syndrome (SS) and systemic lupus erythematosus (SLE) initially identified by whole genome DNA pooling. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S791). San Francisco, CA: WILEY-LISS. 2008 Lester, S., Skarratt, K., Gu, B., Downie-Doyle, S., Wiley, J., & Rischmueller, M. (2008). Functional polymorphisms of the P2x<sub>7</sub> gene influence susceptibility to Ro/la autoantibody-positive primary Sjogren's syndrome. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S792). San Francisco, CA: WILEY-LISS.
WoS12007 Nossent, J. C., Rischmueller, M., Zahra, D., Mackay, C., & Lester, S. (2007). Haploid genotypes in the promoter region of the B-lymphocyte activating factor gene are associated with disease susceptibility and increased serum BAFF levels in anti-RO/LA antibody positive primary Sjogren's syndrome. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 135). Barcelona, SPAIN: B M J PUBLISHING GROUP. 2006 Cai, F. Z., Lester, S. E., Lu, T., Keen, H., & Rischmueller, M. (2006). Autonomic dysfunction in primary Sjogren's syndrome: A controlled study.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S252). Washington, DC: WILEY-LISS. 2006 Downie, S., Bayat, N., Rischmueller, M., & Lester, S. (2006). Influence of CTLA-4 haplotypes upon susceptibility and extraglandular manifestations in australian patients with primary Sjogren's syndrome. In ANNALS OF THE RHEUMATIC DISEASES Vol. 65 (pp. 286). Amsterdam, NETHERLANDS: B M J PUBLISHING GROUP. 2003 Rischmueller, M. (2003). Humoral, hormonal and genetic determinants of cholinergic dysfunction in Sogren's syndrome. In ARTHRITIS RESEARCH & THERAPY Vol. 5 (pp. S50). Miyakazi, JAPAN: BIOMED CENTRAL LTD.
2003 Roberts-Thomson, P. J., Male, D., Walker, J. G., Cox, S., Rischmueller, M., Pile, K., . . . Turner, D. (2003). Genetic instability in scleroderma. In ANNALS OF THE RHEUMATIC DISEASES Vol. 62 (pp. 104). LISBON, PORTUGAL: B M J PUBLISHING GROUP. 2003 Whittle, S., Lester, S. E., Downie-Doyle, S., Pile, K. D., & Rischmueller, M. (2003). Estrogen receptor alpha IVS1-401 (T/C) polymorphism in primary Sjogren's syndrome.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S567). ORLANDO, FLORIDA: WILEY-LISS. 1999 Limaye, V., Lester, S., Downie, S., Pile, K., Bardy, P., Gordon, T. P., & Rischmueller, M. (1999). The interleukin-10 GCC promoter is not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. In ARTHRITIS AND RHEUMATISM Vol. 42 (pp. S139). LIPPINCOTT WILLIAMS & WILKINS. 1997 McCluskey, J., Reynolds, P., Rischmueller, M., Keech, C., Lester, S., & Gordon, T. P. (1997). Incompletetolerance to nuclear self-antigens: a model for HLA-restricted induction and diversification of autoantibodies in systemic autoimmunity. In D. Charron (Ed.), HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE (pp. 48-59). ST MALO, FRANCE: EDITIONS EDK. -
Conference Items
Year Citation 2022 Fairley, J., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2022). Clinical Characteristics and Survival of Combined Pulmonary Arterial Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Poster session presented at the meeting of Abstracts of the ACR Convergence 2022, as published in Arthritis & Rheumatology. Philadelphia, PA: Wiley.
2020 van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2020). MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS. Poster session presented at the meeting of JCR-JOURNAL OF CLINICAL RHEUMATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. 2020 Singh, M., Jackson, K., Wang, J. J., Schofield, P., Field, M., Rischmueller, M., . . . Reed, J. (2020). GENOMIC ANALYSIS OF B CELLS PRODUCING PATHOGENIC RHEUMATOID FACTORS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Rubbert-Roth, A., Enejosa, J., Pangan, A., Xavier, R., Haraoui, B., Rischmueller, M., . . . Genovese, M. C. (2020). EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP.
WoS52020 Khatri, B., Reksten, T. R., Tessneer, K. L., Rasmussen, A., Scofield, R. H., Bowman, S. J., . . . Lessard, C. (2020). GENOME-WIDE ASSOCIATION STUDY OF SJOGREN'S SYNDROME IDENTIFIES TEN NEW RISK LOCI. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP.
WoS72020 Van Vollenhoven, R., Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R., Howard, M., . . . Strand, V. (2020). UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP.
WoS22020 Verstappen, G. M., Tempany, J. C., Cheon, H., Farchione, A., Downie-Doyle, S., Rischmueller, M., . . . Bryant, V. L. (2020). STRATIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME BY MEASURING B-CELL HEALTH. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP.
2020 Wiley, M. M., Khatri, B., Tessneer, K. L., Joachims, M. L., Stolarczyk, A. M., Rasmussen, A., . . . Lessard, C. (2020). FUNCTIONAL EVALUATION OF THE SJOGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVAL. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP.
2020 Khatri, B., Reksten, T. R., Tessneer, K., Rasmussen, A., Scofield, R., Bowman, S., . . . Lessard, C. (2020). Genome-wide Association Study of Sjogren's Syndrome Identifies Ten New Risk Loci. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. ELECTR NETWORK: WILEY. 2020 van Vollenhoven, R., Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R., Howard, M., . . . Strand, V. (2020). Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. ELECTR NETWORK: WILEY. 2019 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2019). Clinical Characteristics and Survival in Systemic Sclerosis-mixed Connective Tissue Disease and Systemic Sclerosis-overlap Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. GA, Atlanta: WILEY. 2019 van Vollenhoven, R., Takeuchi, T., Pangan, A., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2019). Monotherapy with Upadacitinib in MTX-naive Patients with Rheumatoid Arthritis: Results at 48 Weeks. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. GA, Atlanta: WILEY. 2019 van Vollenhoven, R., Takeuchi, T., Pangan, A., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2019). MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-EARLY STUDY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
WoS62018 March, L., Willers, C., Ellis, J., Cobb, J., Lester, S., Buchbinder, R., . . . Murray, K. (2018). THE AUSTRALIAN ARTHRITIS AND AUTOIMMUNE BIOBANK COLLABORATIVE (A3BC) PROTOCOL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2018 Vincent, F., Kandane-Rathnayake, R., Hoi, A., Slavin, L., Godsell, J., Kitching, A. R., . . . Morand, E. (2018). URINARY B CELL-ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY (BAFF) IN SYSTEMIC LUPUS ERYTHEMATOSUS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2017 Merriman, T. R., Cadzow, M., Merriman, M. E., Phipps-Green, A., Topless, R., Abhishek, A., . . . Major, T. (2017). A Genome-Wide Association Study of Gout in People of European Ancestry. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Retamozo, S., Brito-Zeron, P., Zeher, M., Sivils, K. L., Seror, R., Mandl, T., . . . Ramos-Casals, M. (2017). Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjogren Syndrome: Analysis of 9302 Patients from the Big Data International Sjogren Cohort. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY.
WoS22017 Walker, J. G., Nikpour, M., Huq, M., Patterson, K., Roberts-Thomson, P., Proudman, S., . . . Fritzler, M. J. (2017). Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Li, X., Baldini, C., . . . Ramos-Casals, M. (2017). BASELINE ESSDAI/ DAS SCORES IN 8061 PATIENTS WITH PRIMARY SJOGREN SYNDROME: CHARACTERIZATION OF SYSTEMIC DISEASE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
WoS12017 Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Li, X., Baldini, C., . . . Ramos-Casals, M. (2017). PREDICTING SURVIVAL IN 6240 PATIENTS WITH PRIMARY SJOGREN' SYNDROME (BIG DATA SJOGREN PROJECT). Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
2017 Merriman, T. R., Cadzow, M., Merriman, M., Phipps-Green, A., Topless, R., Abhishek, A., . . . Flynn, T. (2017). A GENOME-WIDE ASSOCIATION STUDY OF GOUT IN PEOPLE OF EUROPEAN ANCESTRY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
2017 Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Seror, R., Mandl, T., . . . Ramos-Casals, M. (2017). ANALYSIS OF 9302 PATIENTS FROM THE BIG DATA INTERNATIONAL PRIMARY SJOGREN SYNDROME COHORT: CLINICAL PRESENTATION AT DIAGNOSIS OF EUROPEAN VS NON-EUROPEAN PATIENTS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
2016 Lau, A. H. Y., Lester, S., Moraitis, S., Ou, J., Rischmueller, M., Wormald, P. J., & Vreugde, S. (2016). Tertiary Lymphoid Organ in Chronic Rhinosinusitis. Poster session presented at the meeting of 2016 ASMR South Australian Scientific Meeting. Convention Centre, Adelaide, South Australia, Australia. 2016 Joachims, M. L., Adrianto, I., Johnston, A., Ice, J., Rasmussen, A., Bowman, S., . . . Lessard, C. J. (2016). Identification and Characterization of Sjogren's Syndrome-Associated Genetic Variants in the IL12A and DDX6-CXCR5 Loci. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. 2016 Lessard, C. J., Adrianto, I., Ice, J., Rasmussen, A., Grundahl, K., Kelly, J. A., . . . Sivils, K. L. (2016). Genome-Wide Association Study Identifies Novel Sjogren's Syndrome Risk Loci in the Regions of NAB1, TYK2, and PTTG1-mir146a. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. 2016 Lessard, C., Li, H., Ice, J. A., Adrianto, I., Rasmussen, A., Lewis, D. M., . . . Sivils, K. L. (2016). IDENTIFICATION OF SJOGREN'S SYNDROME RISK LOCI NEAR TNFAIP3 AND PRDM1. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP.
2016 Hsu, V., Denton, C. P., Domsic, R. T., Furst, D. E., Rischmueller, M., Stanislav, M., . . . Choi, S. (2016). A Phase 2 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness in Subjects with Systemic Sclerosis with Interstitial Lung Disease. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY.
WoS12016 Sharma, R., Harris, V. M., Cavett, J., Kurien, B. T., Liu, K., Koelsch, K. A., . . . Miceli-Richard, C. (2016). Very Rare X Chromosome Abnormalities in SLE and SjoGren's May Localize X Gene Dose Effect. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. 2015 Lessard, C., Li, H., Ice, J. A., Adrianto, I., Montgomery, C. G., Alevizos, I., . . . Sivils, K. L. (2015). IDENTIFICATION OF A SJOGREN'S SYNDROME-ASSOCIATED VARIANT THAT INFLUENCES OAS1 ISOFORM SWITCHING AND PROTEIN EXPRESSION. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP.
2015 Maundrell, A., Wiese, M., Lester, S., Rischmueller, M., Cleland, L., Blumbergs, P., & Limaye, V. (2015). SINGLE NUCLEOTIDE POLYMORPHISMS IN THE PROTEIN TYROSINE PHOSPHATASE (PTPN22) GENE ARE ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC INFLAMMATORY MYOSITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Lau, A., Bosco, M., Lester, S., Roscioli, E., Zalewski, P., & Rischmueller, M. (2015). ARA3 Inflammasome activation in salivary gland epithelial cells - a disease model for primary sjögren's syndrome. Poster session presented at the meeting of Abstracts of the Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, as published in Internal Medicine Journal. Adelaide, South Australia: Wiley.
2015 Wechalekar, M., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). FOOT SYNOVITIS IN PATIENTS IN APPARENT REMISSION IS ASSOCIATED WITH WORSE LONG-TERM FUNCTIONAL OUTCOMES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. (2015). Clinical Correlates of Monospecific Anti-Ro52/TRIM21 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Quebec, CANADA: J RHEUMATOL PUBL CO. 2015 Lessard, C. J., Li, H., Ice, J., Adrianto, I., Rasmussen, A., Grundahl, K., . . . Sivils, K. L. (2015). Identification of Novel Sjogren's Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. 2015 Harris, V. M., Cavett, J., Kurien, B., Liu, K., Koelsch, K. A., Radfar, L., . . . Scofield, R. H. (2015). Klinefelter's Syndrome (47,XXY) Among Men with Sjogren's Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY-BLACKWELL. 2014 Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2014). A COMPARISON OF THE PREDICTIVE ACCURACY OF THREE SCREENING MODELS (DETECT V. ESC/ERS V. ASIG) FOR PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. Hobart, Tasmania: WILEY-BLACKWELL. 2014 Rasheed, H., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Merriman, T. R. (2014). Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. MA, Boston: WILEY. 2014 Kremer, J., Halland, A., Rischmueller, M., Major, G., Taylor, A., Brzosko, M., . . . Fleischmann, R. (2014). LITHE: 5-YEAR FOLLOW-UP DATA DEMONSTRATE MAINTENANCE OF CLINICAL EFFICACY OVER TIME WITH THE USE OF TOCILIZUMAN (TCZ) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) (ENCORE). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2014 Genovese, M., Sebba, A., Youssef, P., Rischmueller, M., Jones, G., Rubbert-Roth, A., . . . Van Vollenhoven, R. (2014). LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2014 Liu, K., Kurien, B., Zimmerman, S., Kaufman, K., Mariette, X., Kottyan, L., . . . Scofield, R. (2014). X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in systemic lupus erythematosus and Sjogren's syndrome. Poster session presented at the meeting of JOURNAL OF IMMUNOLOGY. AMER ASSOC IMMUNOLOGISTS. 2014 Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Witcombe, D., . . . Thirunavukkarasu, K. (2014). TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR: LONG-TERM EXTENSION STUDY OUTCOMES IN AN AUSTRALIAN RHEUMATOID ARTHRITIS POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
WoS12014 Hao, Y. J., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology. 2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology. 2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
2014 Lester, S., Patterson, K., Walker, J., Charlesworth, J., Stankovich, J., Stevens, W., . . . Zochling, J. (2014). Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
2014 Patterson, K., Roberts-Thomson, P., Lester, S., Proudman, S., Rischmueller, M., Stevens, W., . . . Walker, J. (2014). Autoantibody associations among a well-characterized Australian systemic sclerosis (SSc) cohort. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
2013 Lessard, C. J., Li, H., Ice, J. A., Adrianto, I., Jonsson, R., Illei, G. G., . . . Sivils, K. M. (2013). IDENTIFICATION OF MULTIPLE SJOGREN'S SYNDROME SUSCEPTIBILITY LOCI. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP.
WoS22013 Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Witcombe, D., . . . Thirunavukkarasu, K. (2013). TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR: PATIENT REPORTED OUTCOMES IN AN AUSTRALIAN PHASE 3 RHEUMATOID ARTHRITIS STUDY POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2013 Hall, S., Bird, P., Rischmueller, M., Rubbert-Roth, A., Cantagrel, A., Leszczynski, P., . . . Burmester, G. (2013). SUMMACTA: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF TOCILIZUMAB SUBCUTANEOUS (SC) VERSUS TOCILIZUMAB INTRAVENOUS (IV), IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS (RA). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2013 Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Dozmorov, M. G., Jonsson, R., . . . Sivils, K. L. (2013). Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding.. Poster session presented at the meeting of ARTHRITIS AND RHEUMATISM. San Diego, CA: WILEY-BLACKWELL. 2013 Dunstan, E., Lester, S., Hewitt, A., Rischmueller, M., & Hill, C. (2013). NO ASSOCIATION BETWEEN FCGR3B, TLR4 AND SOUTH AUSTRALIAN BIOPSY-PROVEN GIANT CELL ARTERITIS PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2012 Dunstan, E., Lester, S., Black, R., Davatchi, F., Nadji, A., Bayat, N., . . . Shahram, F. (2012). THE CTLA4 GENE IS A POTENTIAL DISEASE MODIFYING GENE IN BEHCET'S DISEASE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2012 Charlesworth, J., Stankovich, J., Lewis, P., Byron, J., Stevens, W., Sahhar, J., . . . Zochling, J. (2012). An immunochip based interrogation of scleroderma susceptibility variants. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
2012 Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Kwok, K., & Thirunavukkarasu, K. (2012). TOFACITINIB (CP-690,550), AN ORAL JANUS KINASE INHIBITOR: POOLED PHASE 3 ANALYSIS IN AN AUSTRALIAN RHEUMATOID ARTHRITIS STUDY POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
WoS12012 Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. G. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Abstracts of the 2012 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Washington, D.C.: Wiley-Blackwell.
2012 Graf, S., Lester, S., Nossent, H., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case control study and meta-analysis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
2012 Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
WoS52011 Nossent, J., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). LOW COPY NUMBER OF FCGAMMARECEPTOR IIIB PREDISPOSES TO SJOGREN'S SYNDROME AS WELL AS SLE, BUT CONTRIBUTES TO DISEASE THROUGH DIFFERENT PATHWAYS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2000 Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Bardy, P., Gordon, T., & Rischmueller, M. (2000). The interleukin-10 GCC promoter is not associated with anti-Ro autoantibodies in primary Sjgren's syndrome. Poster session presented at the meeting of Abstracts of the Annual Scientific Meeting of the Australian Rheumatology Association. Hobart, Tasmania. 2000 Downie-Doyle, S., Lester, S., Bardy, P., Gordon, T., Rischmueller, M., & Pile, K. (2000). Immunoglobulin Kappa light chain gene alleles are not associated with primary Sjogren's Syndrome (SS). Poster session presented at the meeting of Arthritis & Rheumatism. Philadelphia, Pennsylvania: American College of Rheumatology. 2000 Pile, K., Rischmueller, M., Jaksic, W., Champion, G., McNeil, J., & Wickham, N. (2000). High dose chemotherapy without autologous stem cell reinfusion in the treatment of RA. Poster session presented at the meeting of Abstract Supplement - Arthritis & Rheumatism 2000 Annual Scientific Meeting. Philadelphia, USA: American College of Rheumatology. 2000 Lester, S., Downie-Doyle, S., Gordon, T., Bardy, P., Rischmueller, M., & Pile, K. (2000). The IL4-R a Q576R polymorphism is not associated with primary Sjogren's Syndrome (SS). Poster session presented at the meeting of Abstract supplement - Arthritis & Rheumatism 2000 Annual Scientific Meeting. Philadelphia, USA: American College of Rheumatology.
Grants
| 2017 | The Hospital Research Foundation (HRF) Project Grant: “Australian Arthritis & Autoimmune Biobank Collaborative (A3BC)” ($223,000, 2017-2020). Hill CL, Rischmueller M, March LM. |
| 2017 | Australian Arthritis & Autoimmune Biobank Collaborative: “Establishment of BHI Biobank” ($150,000, 2017-2020). Hill CL, Rischmueller M, March LM. |
| 2013 | Arthritis Australia Project Grant. “Extraction of DNA from GCA patient biopsies”. ($25,000). Brown MA, Merriman T, Rischmueller M, Hewitt A, Harrison A, Hill C. |
| 2012 | Associate Investigator on an NHMRC project grant. “How does disruption of Serinc1 expression affect lymphocyte function and the development of autoimmunity?” Dr T Brodnicki, St Vincent’s Institute of Medical Research. |
| 2011 | Arthritis Australia Project Grant “The Australasian Arthritis Genomics Recruitment Collaborative: Infrastructure for establishing a quality clinical resource for genetic research.” ($50,000). Brown M, Merriman T, Rischmueller M. |
-
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2015 - 2018 Co-Supervisor An Immunological Perspective of the Mucosal Inflammation in Chronic Rhinosinusitis – Lymphoid Neo-organogenesis and Humoral Immunity Doctor of Philosophy Doctorate Full Time Mr Aden Lau
-
Committee Memberships
Date Role Committee Institution Country 2016 - ongoing Member Australasian Society for Ultrasound Medicine - - 2016 - ongoing Member EXcite Immunology Weekend (Pfizer) National Industry Symposium Steering Committees - 2016 - ongoing Member 14th International Sjogren’s Syndrome Symposium Scientific Committee - - 2015 - ongoing Member Scientific Review Subcommittee Human Research Ethics Committee (TQEH/LMH/MH) - 2014 - ongoing Member Gout Special Interest Forum (Astra-Zeneca) - - 2013 - ongoing Member Australian Medical Association - - 2013 - ongoing Secretary Medical Staff Society The Queen Elizabeth Hospital - 2007 - 2012 Member SA Advanced Rheumatology Trainee Selection Committee Royal Australian College of Physicians -
Connect With Me
External Profiles
